Cydan Announces Formation of Tiburio Therapeutics Inc. to Develop Treatments for Rare Neuroendocrine Tumors and Endocrine Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2CMAwkb
via IFTTT